Author

Ellen Chuang

Observed names: E Chuang, E J Chuang, E. Chuang

Observed institutions: Hospital for Special Surgery, National Institutes of Health, United States Food and Drug Administration, NewYork–Presbyterian Hospital, Howard Hughes Medical Institute, SUNY Upstate Medical University, Cornell University, Stony Brook University Hospital, University of Chicago, University of Kansas Medical Center, Harrington Cancer Center, Weill Cornell Medicine, Indiana University Indianapolis, Weill Cornell Medical Center

OpenAlex ID: A5111637655

Molecular Basis of T Cell Inactivation by CTLA-4

1998 · Kyung-Mi Lee, Ellen Chuang, et al. · Science · 685

Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205

2014 · Madhav V. Dhodapkar, Mario Sznol, et al. · Science Translational Medicine · 367

Regulation of surface and intracellular expression of CTLA4 on mouse T cells

1996 · M L Alegre, P J Noel, et al. · The Journal of Immunology · 337

The CD28 and CTLA-4 Receptors Associate with the Serine/Threonine Phosphatase PP2A

2000 · Ellen Chuang, Timothy S. Fisher, et al. · Immunity · 302

PDF

Structural Analysis of CTLA-4 Function In Vivo

2000 · Emma L Masteller, Ellen Chuang, et al. · The Journal of Immunology · 252

Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane

2009 · Linda T. Vahdat, Brian Pruitt, et al. · Journal of Clinical Oncology · 244

PDF

Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases

2016 · Nancy Chan, Amy Willis, et al. · Clinical Cancer Research · 233

Interaction of CTLA-4 with the clathrin-associated protein AP50 results in ligand-independent endocytosis that limits cell surface expression

1997 · E Chuang, M L Alegre, et al. · The Journal of Immunology · 225

Critical Binding and Regulatory Interactions between Ras and Raf Occur through a Small, Stable N-Terminal Domain of Raf and Specific Ras Effector Residues

1994 · E Chuang, D Barnard, et al. · Molecular and Cellular Biology · 184

Regulation of Cytotoxic T Lymphocyte-Associated Molecule-4 by Src Kinases

1999 · Ellen Chuang, Kyung-Mi Lee, et al. · The Journal of Immunology · 119

Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse

2013 · S. Jain, J. Cohen, et al. · Annals of Oncology · 99

PDF

Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer

2007 · Rakhi P. Naik, David Jin, et al. · Breast Cancer Research and Treatment · 94

Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo

2011 · B. Ramaswamy, W. Fiskus, et al. · Breast Cancer Research and Treatment · 88

Employment After a Breast Cancer Diagnosis: A Qualitative Study of Ethnically Diverse Urban Women

2011 · V. S. Blinder, M. M. Murphy, et al. · Journal of Community Health · 79

Clinical and Translational Results of a Phase II, Randomized Trial of an Anti–IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy

2015 · William J. Gradishar, Denise A. Yardley, et al. · Clinical Cancer Research · 73

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

2015 · Sasha E Stanton, Maureen M Ward, et al. · BMC Cancer · 71

PDF

Identification of the sites of interaction between c-Raf-1 and Ras-GTP.

1995 · D Barnard, B Diaz, et al. · PubMed · 56

Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy

2015 · Tessa Cigler, Devora Isseroff, et al. · Clinical Breast Cancer · 51

An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer

2009 · M. Kozloff, E. Chuang, et al. · Annals of Oncology · 50

PDF

IgG immune complexes inhibit IFN-gamma-induced transcription of the Fc gamma RI gene in human monocytes by preventing the tyrosine phosphorylation of the p91 (Stat1) transcription factor.

1995 · G M Feldman, E J Chuang, et al. · The Journal of Immunology · 49

Concurrent Invasive Ductal Carcinoma and Chronic Lymphocytic Leukemia Manifesting as a Collision Tumor in Breast

2007 · Kevin J. Cheung, Wayne Tam, et al. · The Breast Journal · 37

PDF

Breast Cancer Subtypes in Asian-Americans Differ According to Asian Ethnic Group

2012 · Ellen Chuang, Paul Christos, et al. · Journal of Immigrant and Minority Health · 33

Incremental increase in VEGFR1+ hematopoietic progenitor cells and VEGFR2+ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients

2011 · Sarika Jain, Maureen M. Ward, et al. · Breast Cancer Research and Treatment · 31

Ixabepilone‐induced mitochondria and sensory axon loss in breast cancer patients

2014 · Gigi J. Ebenezer, Karen Carlson, et al. · Annals of Clinical and Translational Neurology · 30

PDF

Transgenic Expression of CTLA-4 Controls Lymphoproliferation in IL-2-Deficient Mice

2004 · Kwang Woo Hwang, William B Sweatt, et al. · The Journal of Immunology · 24

Works count: 82

Citation count: 3,875

H-index: 24

I10-index: 27